Pet Genetic Testing Companies Are Making Promises They Can’t Keep
By Jessica Hekman,
Undark
| 09. 13. 2018
The promise of a sequenced genome is like a wrapped present, containing exactly what you always wanted but never knew you could get: predictions of all your future health problems and instructions for how to avoid them. Pet owners are the latest to fall prey to the myth of the “magic genome,” hoping that genetic testing will keep their animal companions alive and healthy for longer than ever before. The claims of many genetic testing companies encourage these unrealistic expectations.
The pet genetic testing industry has boomed in recent years as sequencing technology has improved and costs have plummeted. Several companies now tout direct-to-consumer tests that can screen companion animals, mostly dogs, for more than 150 genetic diseases including heart disease, kidney disease, and epilepsy. As a veterinarian and genomics researcher, I encounter dog owners who truly believe that genetic sequencing will save their animals’ lives.
What most pet genetic testing companies fail to make clear, though, is that genetic testing is riddled with uncertainty. Not all pets that test “clear” for a disease are truly safe from that condition...
Related Articles
GeneWatch UK has prepared a briefing on the genetic modification of nature for the International Union for Conservation of Nature (IUCN) Congress in October 2025
The upcoming Congress claims to be “where the world comes together to set priorities and drive conservation and sustainable development action.” A major concern for those on the outside is that the Congress may advance plans to develop and encourage the use of synthetic biology in nature conservation. This could at first glance sound like...
By Aaron Ginn, The Washington Post | 09.12.2025
Earlier this year, I had dinner in D.C. with Jensen Huang, the president and chief executive of Nvidia. At one point, he said something that struck me: “Why is everyone here so negative?”
He wasn’t referring to the economy...
By Roni Caryn Rabin, The New York Times | 08.25.2025
Scientists have dreamed for centuries about using animal organs to treat ailing humans. In recent years, those efforts have begun to bear fruit: Researchers have begun transplanting the hearts and kidneys of genetically modified pigs into patients, with varying degrees...
The Center for Genetics and Society is delighted to recommend the current edition of GMWatch Review – Number 589. UK-based GMWatch, a long-standing ally, was founded in 1998 by Jonathan Matthews as an independent organization seeking to counter the enormous corporate political power and propaganda of the GMO industry and its supporters. Matthews and Claire Robinson are its directors and managing editors.
CGS works to ensure that social justice, equity, human rights, and democratic governance are front...